Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series
Actas Dermosifiliogr. 2024 Feb 17:S0001-7310(24)00138-8.
doi: 10.1016/j.ad.2023.04.042.
Online ahead of print.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia (Valencia), Spain. Electronic address: javimelgo2017@gmail.com.
- 2 Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia (Valencia), Spain.
No abstract available